DRIVE is attending ESCAIDE (Malta 21.-23.11.) with several presentations at parallel sessions and moderated poster session.
Come to discuss with the DRIVE consortium, contact us via @drive_eu.
Please find here the schedule of the presentations given by DRIVE consortium members at the event. Some of these focus mainly on work done on other projects as ADVANCE or I-MOVE +.
THURSDAY, 23 NOVEMBER 2018
15:40-16:40: Moderated poster session B tracks 9-16
Track 15: Influenza, TB and other respiratory viruses (2): Vaccination and interventions
O17.4. Seasonal influenza vaccination in 2017/18 and two previous seasons lowered the risk of influenza B in 2017/18 in the elderly, Ulrike Baum
Poster by Ulrike Baum as PDF
A presentation by Ulrike Baum yesterday at #ESCAIDE:
Despite the mismatch between the circulating and the vaccine B virus, repeat IIV3 vaccination protected against influenza B suggesting the presence of cross-protection between the lineages. https://t.co/v0QkGhLU3i@ESCAIDE pic.twitter.com/tW8IfBzCpP
— DRIVE Project (@drive_eu) 23. marraskuuta 2018
FRIDAY, 23 NOVEMBER 2018
11:00-12:40: Parallel Session 17: Influenza and other respiratory viruses: epidemiology and surveillance
17.4. Previous exposure to natural infection matters – The effect of influenza A infection in 2016/17 on influenza A and B infection in 2017/18 in the Finnish elderly, Ulrike Baum
Presentation by Ulrike Baum as PDF
14:30-15:30: Parallel Session 19: Vaccine-preventable diseases (5): preparedness:
O19.1. Guidance for the governance of public-private collaborations in vaccine post-marketing settings in Europe, ADVANCE-project Laurence Torcel-Pagnon.
#Advance project presents their governance model for neutral and transparent collaboration between public and private collaboration #ESCAIDE pic.twitter.com/CwDSNzifzd
— Javier Diez-Domingo (@javierdiezd) November 23, 2018
Public private partnership collaboration model use in vaccine post marketing settings #ESCAIDE #transparency #guidelines #stakeholders #EMA pic.twitter.com/38AeVNM9rJ
— Charmaine Gauci (@CGauci1) 23. marraskuuta 2018
14:30-15:30: Parallel Session 20: Influenza and other respiratory viruses (2): vaccination
O20.2. High live-attenuated influenza vaccine effectiveness against influenza B in two-year-olds, 2017/18, Finland, Ulrike Baum
#influenza season 2017-2018, #LAIV vaccine performed better than #inactivated #TIV #Finland says Ulrike Baum with #national #register based data #cohort analysis. #datatekeehyvää @THLorg @drive_eu pic.twitter.com/uV9lFobUn5
— Hanna Nohynek (@HNohynek) 23. marraskuuta 2018
15:40-16:40: Moderated session C – Tracks 19-24
Track 23: Policy approaches and evaluation
C23.6. Seasonal influenza vaccine procurement systems in Europe, Anke L. Stuurman
Anke Stuurmans poster as PDF
Anke Stuurman @P95 explored how different #EU countries tender and purchase #influenza #vaccines used in country. Important to know when studying #flu vaccine brand specific #effectiveness @drive_eu @THLorg pic.twitter.com/6UVZe412va
— Hanna Nohynek (@HNohynek) November 23, 2018
DRIVE presentation at ESCAIDE: Seasonal flu vaccines come in multiple flavours: DRIVE wants to know, which brands are used and where?